Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Spuler, S.
Right arrow Articles by Engel, A. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Spuler, S.
Right arrow Articles by Engel, A. G.
NEUROLOGY 1998;50:41-46
© 1998 American Academy of Neurology

Unexpected sarcolemmal complement membrane attack complex deposits on nonnecrotic muscle fibers in muscular dystrophies

Simone Spuler, MD and Andrew G. Engel, MD

From the Department of Neurology, Neuromuscular Laboratory, Mayo Clinic, Rochester, MN.

Address correspondence and reprint requests to Dr. Andrew G. Engel, Department of Neurology, Mayo Clinic, Rochester, MN 55905.

Antibody-dependent complement-mediated muscle fiber injury is a hypothetical immune effector response in inflammatory muscle diseases. Moreover, a sarcolemmal alteration in muscular dystrophies might trigger antibody-independent activation of the alternative complement pathway. We therefore searched for C5b9 complement membrane attack complex (MAC), immunoglobulin (Ig)G, and IgM deposits on nonnecrotic muscle fibers in muscle specimens from 81 patients with inflammatory myopathies, 45 patients with muscular dystrophies, and 19 patients with necrotizing myopathies. Sarcolemmal MAC deposits were present on nonnecrotic fibers (C+ fibers) in only two unusual types of inflammatory myopathy. By contrast, seven of 17 facioscapulohumeral dystrophy, four of nine limb-girdle dystrophy, and three of six merosin (laminin-{alpha}-2)-positive congenital muscular dystrophy but none of the Becker or Duchenne dystrophy specimens harbored C+ fibers. None of the C+ fibers immunostained for IgG or IgM, and none failed to immunostain for CD59 or CD46-inhibitors of the complement cascade. Our findings do not support a role for antibody-dependent complement-mediated muscle fiber injury in the major inflammatory muscle diseases. The cause and pathogenetic significance of the C+ fibers in the different types of muscular dystrophies remains to be elucidated.


Supported by NIH grant NS6277 and an MDA research grant to A.G.E.

Received July 1, 1997. Accepted in final form August 21, 1997.




This article has been cited by other articles:


Home page
Am. J. Pathol.Home page
K. Nagaraju, R. Rawat, E. Veszelovszky, R. Thapliyal, A. Kesari, S. Sparks, N. Raben, P. Plotz, and E. P. Hoffman
Dysferlin Deficiency Enhances Monocyte Phagocytosis: A Model for the Inflammatory Onset of Limb-Girdle Muscular Dystrophy 2B
Am. J. Pathol., March 1, 2008; 172(3): 774 - 785.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
K. Wenzel, J. Zabojszcza, M. Carl, S. Taubert, A. Lass, C. L. Harris, M. Ho, H. Schulz, O. Hummel, N. Hubner, et al.
Increased Susceptibility to Complement Attack due to Down-Regulation of Decay-Accelerating Factor/CD55 in Dysferlin-Deficient Muscular Dystrophy
J. Immunol., November 1, 2005; 175(9): 6219 - 6225.
[Abstract] [Full Text] [PDF]


Home page
J Child NeurolHome page
R. Sakuta, N. Murakami, Y. Jin, T. Nagai, I. Nonaka, and I. Nishino
Diagnostic Significance of Membrane Attack Complex and Vitronectin in Childhood Dermatomyositis
J Child Neurol, July 1, 2005; 20(7): 597 - 602.
[Abstract] [PDF]


Home page
NeurologyHome page
A. A. Amato and R. C. Griggs
Unicorns, dragons, polymyositis, and other mythological beasts
Neurology, August 12, 2003; 61(3): 288 - 289.
[Full Text] [PDF]


Home page
Hum Mol GenetHome page
J. D. Porter, A. P. Merriam, P. Leahy, B. Gong, and S. Khanna
Dissection of temporal gene expression signatures of affected and spared muscle groups in dystrophin-deficient (mdx) mice
Hum. Mol. Genet., August 1, 2003; 12(15): 1813 - 1821.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
B. A. Minassian, R. Aiyar, S. Alic, B. Banwell, M. Villanova, M. Fardeau, J. W. Mandell, V. C. Juel, M. Rafii, M. Auranen, et al.
Narrowing in on the causative defect of an intriguing X-linked myopathy with excessive autophagy
Neurology, August 27, 2002; 59(4): 596 - 601.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
J. D. Porter, S. Khanna, H. J. Kaminski, J. S. Rao, A. P. Merriam, C. R. Richmonds, P. Leahy, J. Li, W. Guo, and F. H. Andrade
A chronic inflammatory response dominates the skeletal muscle molecular signature in dystrophin-deficient mdx mice
Hum. Mol. Genet., February 1, 2002; 11(3): 263 - 272.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
D. Selcen, G. Stilling, and A. G. Engel
The earliest pathologic alterations in dysferlinopathy
Neurology, June 12, 2001; 56(11): 1472 - 1481.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
J. Frenette, B. Cai, and J. G. Tidball
Complement Activation Promotes Muscle Inflammation during Modified Muscle Use
Am. J. Pathol., June 1, 2000; 156(6): 2103 - 2110.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1998 by AAN Enterprises, Inc.